Literature DB >> 13150002

Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia.

L R WASSERMAN.   

Abstract

Entities:  

Keywords:  POLYCYTHEMIA VERA

Mesh：

Year:  1954        PMID： 13150002      PMCID： PMC1804490     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  21 in total

1.  The myeloproliferative disorders with special reference to myelofibrosis.

Authors:  M S R HUTT; J L PINNIGER; G WETHERLEY-MEIN
Journal:  Blood       Date:  1953-04       Impact factor: 22.113

2.  The nature and treatment of polycythemia; studies on 263 patients.

Authors:  J H LAWRENCE; N I BERLIN; R L HUFF
Journal:  Medicine (Baltimore)       Date:  1953-09       Impact factor: 1.889

3.  Panmyelosis and chronic granulocytic leukemia.

Authors:  B BLACK-SCHAFFER; L D STODDARD
Journal:  Am J Pathol       Date:  1953 May-Jun       Impact factor: 4.307

4.  Gout, leukaemia, and polycythaemia.

Authors:  R A HICKLING
Journal:  Lancet       Date:  1953-01-10       Impact factor: 79.321

5.  Fundamental stimulus for erythropoiesis.

Authors:  W C GRANT; W S ROOT
Journal:  Physiol Rev       Date:  1952-10       Impact factor: 37.312

6.  Some speculations on the myeloproliferative syndromes.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1951-04       Impact factor: 22.113

7.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

8.  The treatment of polycythemia vera with radioactive phosphorus.

Authors:  B K WISEMAN; R J ROHN; B A BOURONCLE; W G MYERS
Journal:  Ann Intern Med       Date:  1951-02       Impact factor: 25.391

9.  Treatment of polycythemia vera with triethylene melamine; summary of thirty cases.

Authors:  N ROSENTHAL; R L ROSENTHAL
Journal:  AMA Arch Intern Med       Date:  1952-09

10.  Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders.

Authors:  R L HUFF; T G HENNESSY; R E AUSTIN; J F GARCIA; B M ROBERTS; J H LAWRENCE
Journal:  J Clin Invest       Date:  1950-08       Impact factor: 14.808
View more
  12 in total

1.  MALIGNANT MYELOSCLEROSIS.

Authors:  S M LEWIS; L SZUR
Journal:  Br Med J       Date:  1963-08-24

2.  Surgical implications of polycythemia vera.

Authors:  W T FITTS; A ERDE; G W PESKIN; J W FROST
Journal:  Ann Surg       Date:  1960-09       Impact factor: 12.969

3.  [Treatment of polycythemia rubra vera with radioactive phosphorus].

Authors:  P DOERING
Journal:  Klin Wochenschr       Date:  1956-11-15

4.  Present status of 32P-therapy in management of polycythemia vera.

Authors:  G Meuret
Journal:  Klin Wochenschr       Date:  1975-06-15

5.  Haemostatic defects in polycythaemia vera.

Authors:  N E Stathakis; A G Papayannis; G Arapakis; C Gardikas
Journal:  Blut       Date:  1974-08

6.  Localized, multiform, sub-periosteal hyperplasia and generalized osteomyelosclerosis in magnesium-deficient rats.

Authors:  B J Hunt; L F Bélanger
Journal:  Calcif Tissue Res       Date:  1972

7.  Acute necrotizing encephalitis. Report of a case associated with polycythemia vera.

Authors:  G J Hum
Journal:  Calif Med       Date:  1968-03

8.  [Late results of radiophosphorus therapy in polycythemia vera].

Authors:  R Höfer; J Kühböck
Journal:  Blut       Date:  1970-04

9.  Agnogenic myeloid metaplasia: role of splenectomy.

Authors:  C Marks; M Ahmadi
Journal:  Postgrad Med J       Date:  1969-04       Impact factor: 2.401

10.  Bone changes in polycythaemia vera and myelosclerosis.

Authors:  B E Roberts; C G Woods; D W Miles; C R Paterson
Journal:  J Clin Pathol       Date:  1969-11       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.